Floatz logo

SACUBITRIL

Sacubitril/Valsartan

Beijing Friendship HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Sacubitril/Valsartan cohort.

Asset / SponsorPhaseRating
SACUBITRIL VALSARTAN
Silesian Centre for Heart Diseases
Phase 4BB
VALSARTAN
Beijing Friendship Hospital
D

Same molecule, other indications

SACUBITRIL is also rated in:

hypertensive disorderDormant
BB
Indicative ·
67 / 100
View asset →
Natriuretic PeptidesDormant
B
Indicative ·
57 / 100
View asset →
Renin-Angiotensin-Aldosterone SystemDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →